Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/30/2019 | Senseonics Holdings, Inc. | SENS | Grant | Stock Option (right to buy) | 86.9k | $0.00 | $0 | | 05/30/2019 |
01/02/2019 | Senseonics Holdings, Inc. | SENS | Grant | Common Stock | 3.6k | $2.69 | $9.7k | | 01/02/2019 |
10/11/2018 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (Right to Buy) | 14.8k | $27.92 | $412.4k | | 10/11/2018 |
10/01/2018 | Senseonics Holdings, Inc. | SENS | Grant | Common Stock | 2.1k | $4.54 | $9.7k | | 10/01/2018 |
09/07/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 3M | $1.67 | $5M | See Note 3 | 09/07/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Series B Preferred Stock | 3.6M | $0.00 | $0 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Series C Preferred Stock | 3.3M | $0.00 | $0 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Series D Preferred Stock | 16.5M | $0.00 | $0 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Other (disposition) | Warrant to purchase Series D Preferred Stock | 684.9k | $0.01 | $6.8k | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Other (acquisition) | Warrant to purchase Common Stock | 40.7k | $0.01 | $407 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Common Stock | 515.5k | $0.00 | $0 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Common Stock | 432k | $0.00 | $0 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Common Stock | 980.7k | $0.00 | $0 | See Note 2 | 07/30/2018 |
07/30/2018 | Liquidia Technologies Inc | LQDA | Purchase | Common Stock | 545.5k | $11.00 | $6M | See Note 2 | 07/30/2018 |
07/02/2018 | Senseonics Holdings, Inc. | SENS | Grant | Common Stock | 2.2k | $4.43 | $9.7k | | 07/02/2018 |
06/15/2018 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 15.3k | $3.19 | $48.8k | | 06/15/2018 |
05/30/2018 | Senseonics Holdings, Inc. | SENS | Grant | Stock Option (right to buy) | 50.8k | $0.00 | $0 | | 05/30/2018 |
05/25/2018 | ARDELYX, INC. | ARDX | Grant | Common Stock | 416.7k | $4.00 | $1.7M | See Note 1 | 05/25/2018 |
05/18/2018 | GLYCOMIMETICS INC | GLYC | Grant | Stock Option (right to buy) | 11k | $18.41 | $202.5k | | 05/18/2018 |
05/10/2018 | GLYCOMIMETICS INC | GLYC | Sale | Common Stock | 4k | $17.81 | $71.3k | See Note 1 | 05/10/2018 |
05/10/2018 | GLYCOMIMETICS INC | GLYC | Sale | Common Stock | 5.5k | $17.81 | $98.5k | See Note 1 | 05/10/2018 |
05/10/2018 | GLYCOMIMETICS INC | GLYC | Exercise (in-the-money or at-the-money) | Warrant to Purchase Common Stock (right to buy) | 216k | $0.33 | $71.3k | See Note 1 | 05/10/2018 |
05/10/2018 | GLYCOMIMETICS INC | GLYC | Exercise (in-the-money or at-the-money) | Warrant to Purchase Common Stock (right to buy) | 298.4k | $0.33 | $98.5k | See Note 1 | 05/10/2018 |
05/01/2018 | MULESOFT, INC | MULE | Conversion | Class A Common Stock | 12.7M | $0.00 | $0 | See Note 2 | 05/01/2018 |
05/01/2018 | MULESOFT, INC | MULE | Other | Class A Common Stock | 12.7M | $0.00 | $0 | See Note 2 | 05/01/2018 |
05/01/2018 | MULESOFT, INC | MULE | Conversion | Class B Common Stock | 12.7M | $0.00 | $0 | See Note 2 | 05/01/2018 |
04/23/2018 | Surface Oncology, Inc. | SURF | Purchase | Common Stock | 133.3k | $15.00 | $2M | See Note 2 | 04/23/2018 |
04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Series A Preferred Stock | 7M | $0.00 | $0 | See Note 2 | 04/23/2018 |
04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Common Stock | 3.2M | $0.00 | $0 | See Note 2 | 04/23/2018 |
04/02/2018 | Senseonics Holdings, Inc. | SENS | Grant | Common Stock | 3.1k | $3.10 | $9.7k | | 04/02/2018 |
03/27/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 6M | $1.92 | $11.5M | See Note 3 | 03/26/2018 |
03/27/2018 | Tracon Pharmaceuticals, Inc. | TCON | Purchase | Common Stock | 708k | $2.70 | $1.9M | See Note 2 | 03/27/2018 |
03/27/2018 | Tracon Pharmaceuticals, Inc. | TCON | Purchase | Warrant to Purchase Common Stock | 708k | $2.70 | $1.9M | See Note 2 | 03/27/2018 |
03/26/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 571.2k | $1.90 | $1.1M | See Note 3 | 03/26/2018 |
03/23/2018 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 294.1k | $1.95 | $572.4k | See Note 3 | 03/21/2018 |
|